The Tampon-Delivery Company Whose Customers Call From the Bathroom
When Alexandra Friedman co-founded LOLA, an organic tampon company, she hoped to fulfill the needs of women by engaging them in constant conversation. She recently revealed to Cheddar just how far that conversation has gone at times.
“My favorite tidbit is that customers have actually called us from the bathroom,” Friedman told Cheddar.
She says being in contact with her customers has helped her hone in on the company’s mission.
“We’re women building a brand for women, and we want it to reflect the needs of women throughout their lives,” Friedman told us.
LOLA prides itself on incorporating customer feedback into its products.
Founded in 2013, LOLA is a subscription-based tampon company that offers women organic products. The company offers customizable assortments delivered to your door.
For full interview, [click here](https://cheddar.com/videos/how-lola-is-destigmatizing-periods).
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
